Home › Therapeutic areas › GI/Hepatology › Wilson's Disease

Wilson's Disease (2 companies)

Companies with an active program in Wilson's Disease.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+3 Rare 2 Approved $1.84B 17
PRME Prime Medicine GI/HepatologyRespiratory Rare 1 Phase 1 $699M 3